Effects of monocyte chemoattractant protein‐1, macrophage inflammatory protein‐1α, and interferon‐α2a on P450 enzymes in human hepatocytes in vitro
Abstract Some immunomodulatory agents stimulate the release of cytokines capable of suppressing P450 enzymes and potentially affecting pharmacokinetics of coadministered medications. Cytokines released in response to an immunomodulator in the blood ex vivo can be used to screen for the potential for...
Saved in:
Main Authors: | Maciej Czerwiński (Author), Krystal Gilligan (Author), Kevin Westland (Author), Brian W. Ogilvie (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Monocyte chemoattractant protein-1 in patients with peripheral arterial disease
by: Jana Petrkova, et al.
Published: (2004) -
Association of interferon gamma inducible protein-10, monocyte chemoattractant protein-1, macrophage inflammatory protein-1 alpha, interleukin-6, and rs12252 single nucleotide polymorphism of interferon-induced transmembrane protein-3 gene with the severity of COVID-19 infection
by: Shafia Mulla, et al.
Published: (2022) -
PARK2 mediates interleukin 6 and monocyte chemoattractant protein 1 production by human macrophages.
by: Louis de Léséleuc, et al.
Published: (2013) -
Interferon-γ Stimulates Monocyte Chemotactic Protein-1 Expression by Monocytes
by: J. M. Liebler, et al.
Published: (1994) -
Adipocyte progenitor cells initiate monocyte chemoattractant protein-1-mediated macrophage accumulation in visceral adipose tissue
by: Jennifer L. Kaplan, et al.
Published: (2015)